The global demand for Hydroxychloroquine Market is presumed to reach the valuation of nearly USD 3963.5MN by 2028 from USD 485MN in 2021 with a CAGR of 35% under the study period of 2022 - 2028.
Hydroxychloroquine is a quinoline medicine utilized to treat or prevent malaria. Malaria is common disease in few countries such as Africa, South America, and Southern Asia. As this medicine is not operative against all strains of malaria. Hydroxychloroquine is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Its alternative name is Hydroxychloroquine sulfate and it is sold in the brand name of Plaquenil, Hydroquin, Axemal (in India), Dolquine, Quensyl and Quinoric.
The market is primarily driven by rising occurrences of chronic diseases globally as hydroxychloroquine is used in treatment of number of diseases such as uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus as it is commonly prescribed for these diseases which makes this market steady as number of cases on diseases such as malaria is high every year.For instance, according to WHO (World Health Organization) in 2018, an estimated 228 million cases of malaria happened worldwide compared with 231 million cases in 2017. From this it is also estimated that, there is a constant need of Hydroxychloroquine in treating this disease making the market less vulnerable to outside changes. Recent positive research on treatment of novel coronavirus using Hydroxychloroquine came up with positive signs, which is helping in growing demand of this drug from last one month. However, the drug has some serious side effects which restrains the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of hydroxychloroquine.
The entire hydroxychloroquine market has been sub-categorized into disease indication and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Disease Indication
By Distribution Channel
- Coronavirus disease (COVID 19)
- Lupus Erythematosus
- Rheumatoid Arthritis
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This section covers regional segmentation which accentuates on current and future demand for hydroxychloroquine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Hydroxychloroquine Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hydroxychloroquine market include Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, AphenaPharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical, and Sun Pharmaceutical Industries Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.